Stars align for Discovery Vitality

Discovery CEO Adrian Gore believes the company’s Vitality composite is entering a seminal year, with it looking to crack the US market and ride global tailwinds. 

Gore told Daily Investor that Vitality has a window of opportunity to steal a march on its competitors, who have realised the value that is at stake. 

Discovery is looking to capture a slice of the $130 billion (R2 trillion) in health care fees that Americans pay annually. 

Gore explained that this ambition is built on the extraordinary foundation that Vitality has established with its shared-value model, which is really coming into its own. 

During the annual results presentation, Discovery’s founder spent some time explaining the global tailwinds behind the Vitality business. 

These tailwinds make it the right time for Vitality to expand into key markets, such as the US and Europe, and to continue its growth in the United Kingdom and China. 

“I was trying to show that if you do an analysis of the environment, Vitality really is one of the few scalable solutions we have to a demographic challenge,” Gore explained. 

“Governments have massive debt and no fiscal room. You have an ageing population with a declining number of working-age people, and the cost of healthcare continues rising.”

Gore explained that the cost of healthcare is unique in that technology does not drive prices down, as it does in other sectors. 

“In this situation, you find that the burden on taxpayers becomes untenable unless we find some way to bring healthcare costs down,” he said. 

“The only way you can do that is to compress morbidity. You have to reduce sickness, and that is what we try to do every day at Discovery.”

Gore said it may be a simple analysis, but it shows that the problem Vitality is solving impacts billions of people. 

In some ways, it appears as though Vitality was made for such a situation, with the stars aligning to turn it into a truly global business. 

Its foothold in the United Kingdom has become a dominant business, and its partnership with Ping An in China is extremely lucrative. 

The UK’s National Health Service is an indication of what happens when a state-run system is overburdened and underfunded. 

An increasing number of Britons are engaging with private healthcare and insurance, boosting Vitality UK’s business. 

In China, the situation is slightly different, with the government actively encouraging citizens to use private health insurance rather than a centralised system. 

These are the two paths open to many developed markets worldwide, with Vitality poised to benefit greatly. 

“You can see through the financial numbers that it is remarkable. But, beyond that, it shows just how powerful the model is. We now touch 54 million lives through our partners and us,” Gore said.

The American frontier

The next frontier for Vitality comes in two weeks when it launches Vitality AI to the American market in partnership with Google. 

Vitality already has a presence in the United States through its partnership with John Hancock, although Gore admits this has been subscale. 

Discovery does not plan to launch standalone healthcare offerings under the Vitality brand as it does in the United Kingdom. 

Rather, it will licence the intellectual property and technology to existing insurers in the United States, making this business highly capital-efficient. 

“This is a very measured approach. We have been there for a long time with a suboptimal scale business model, dealing with health plans and employers. The next step is much bigger,” Gore said. 

“We are not betting the house here. This is a low-capital, high-IP business. The market is so big that if we can get a foothold, it makes a massive difference.”

Gore made clear that the US expansion is not a do-or-die moment, as it is only one of many opportunities that Vitality is pursuing. 

“I think given the markets, given the scale of the model, and what we can do, we are excited about it.”

“I think the work with Google and what we’re rolling out in a couple of weeks’ time in New York is very powerful. So, let’s see how we go. But there’s no big bet we’re taking, so to speak.” 

Vitality has been on an acquisition spree in the United States to grow its capabilities. Since 2024, it has snapped up WellSpark, Ramp Health, and Icario. 

These businesses augment Vitality’s offering through specialisations in health coaching, clinical reach, and government plan expertise. 

Icario opens the door for Vitality to gain exposure to the US government’s health insurance plans and greatly expands the American business’s footprint, adding 11 million lives. 

“What we have now in the US and the AI partnership with Google is in the right form. We have made important steps in the American healthcare space,” Gore said. 

“I don’t think it’s a do-or-die situation, but there is a lot of activity in the market, and we must close it down. This part of the business should get to $80 million to $100 million of profit by 2029.”

Gore admits that it will not be easy, with Vitality having to move quickly and marshal its resources to execute in the next three financial years. 

“I think there is a window for what we want to do, and it is a massive opportunity. We have got to make sure that we capitalise while we have that capability.”